Title:Antiviral Medications: Unravelling their Significance in Context to
COVID-19
Volume: 5
Issue: 4
Author(s): Rishabh Chalotra, Amanjot Singh, Shivani Chib, Swati Gautam, Muhammed Amanat, Kakul Chaudhary, Manish Kumar*Randhir Singh*
Affiliation:
- School of Pharmaceutical Sciences, CT University, Ludhiana, 142024, Punjab, India
- Department of Pharmacology, Central University of Punjab, Bathinda, India
Keywords:
COVID-19, antiviral drugs, repurposing, nanotechnology, virus, JN.1.
Abstract: Viruses represent a significant health menace due to their rapid transmissibility and
potential to cause worldwide pandemics, resulting in substantial loss of human life. Antiviral agents
play a pivotal role in mitigating the impact of viral infections. Nonetheless, treating viral infections is
a multifaceted process due to the inherent characteristics of viruses, such as their capacity to undergo
mutations and rapid evolution. Consequently, the effectiveness of current antiviral therapies can be
impeded. This review encompasses the diverse manners in which viruses, emphasizing COVID-19,
affect the human body and elucidates the challenges encountered in formulating efficacious antiviral
treatments. Moreover, the limitations of conventional antiviral therapies are underscored.
Additionally, a comprehensive compendium of 41 antiviral drugs is presented, detailing their
mechanisms of action and routes of administration. Subsequently, the discussion includes 9 drugs
repurposed for treating COVID-19, delineating their primary use as well as any accompanying side
effects. In conclusion, while antiviral drugs remain pivotal in the battle against viral infections, the
obstacles associated with their development and usage warrant careful consideration. Ongoing research
is imperative to devise more potent and less toxic antiviral interventions against COVID-19 infection.